GlassScriptPhysician profile
Thomesha M Barton
NPI 1104054352
$2,058.71
in general payments reported to CMS, 2019-2025
24 companies · $426 in 2025
The $426 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $135 · 2021: $187 · 2022: $202 · 2023: $329 · 2024: $562 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,068 · Education: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.96 |
| Education | $248.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $388.61 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $213.86 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Organon LLC | $203.34 | 2022-2025 | Nexplanon, Jada System |
| Bayer Healthcare Pharmaceuticals INC. | $162.32 | 2019-2025 | |
| Hologic Sales and Service, LLC | $140.93 | 2020-2025 | Thinprep 2000 Processor, Aptima |
| Exact Sciences Corporation | $138.49 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $124.80 | 2020-2023 | Evenity, Prolia |
| Sumitomo Pharma America, INC. | $123.22 | 2023-2024 | Myfembree, Gemtesa |
| Mayne Pharma Commercial LLC | $94.66 | 2021-2025 | |
| Myovant Sciences INC. | $57.53 | 2022 | |
| Mylan Pharmaceuticals INC. | $54.97 | 2019-2021 | |
| Lupin INC. | $50.20 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $44.24 | 2019-2020 | |
| Therapeuticsmd, INC. | $39.05 | 2021-2022 | |
| Exeltis, USA INC. | $31.65 | 2024-2025 | Slynd |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $29.11 | 2019 | |
| Medtronic, INC. | $24.95 | 2024 | Ligasure |
| Roche Diagnostics Corporation | $24.83 | 2019 | |
| Coopersurgical, INC. | $24.52 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $23.47 | 2019 | |
| Scynexis, INC. | $16.78 | 2022 | |
| Meditrina | $16.70 | 2025 | |
| Olympus America INC. | $15.92 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomesha Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.